General Biologicals Corporation (GBC) — Advancing Diagnostics, Empowering Better Health

Founded in 1984, General Biologicals Corporation (GBC) is a pioneer in Taiwan’s in-vitro diagnostics (IVD) industry, originating from the National Hepatitis Prevention Program initiated by the Executive Yuan. For over 40 years, GBC has been committed to developing accurate, innovative, and accessible diagnostic solutions that improve global healthcare outcomes.

As a GMP-certified and ISO 13485-compliant manufacturer, GBC specializes in the research, development, production, and worldwide distribution of IVD products and technologies. Our solutions are trusted in 40+ countries, supporting hospitals, clinical laboratories, blood banks, and healthcare professionals with reliable diagnostic tools.

Our Core Expertise
• Infectious & Respiratory Diseases
• Blood-Borne Viruses
• Fertility & Sexual Health
• Oncology & Tumor Markers
• Human Genetics
• Emerging Infectious Diseases

Leveraging advanced protein and nucleic acid diagnostic platforms, GBC has built a fully integrated value chain — from R&D and manufacturing to clinical applications and laboratory services — driving innovation in precision diagnostics.

Looking ahead, GBC is expanding beyond traditional IVD into high-value, integrated healthcare solutions through its subsidiaries:
• CurieMed & Danner Lab — Digital medical diagnostics and clinical laboratory services
• GBP — Antimicrobial peptide (AMP) drug development and consumer healthcare applications

With global reach, cutting-edge technologies, and a mission to make world-class diagnostics affordable and accessible to all, GBC continues to transform healthcare and empower better lives.

技嘉科技身為主機板及顯示卡產品的領導品牌，我們體認到企業營運規模愈大，對經濟、環境及社會之影響及責任也愈大 - 企業社會責任早已不是口號，而是技嘉科技身為地球村一員的使命與義務。因此我們重視公司良善治理、堅持永續經營、強調誠信、自律、守法，積極在各方面追求卓越。技嘉科技的經營道路上，不僅視永續發展為核心志業，亦致力尋求與股東、員工、客戶及其他利害相關者之間利益平衡，積極推動技嘉科技核心業務與永續發展結合，發揮企業的實質影響力，打造生產、生活、與生態三生一體的營運模式，讓生態及社會更美好，期許在「創新科技 美化人生」的企業宗旨下，邁向永續、無限的未來！

Golden Bridge Electech Inc. (GBE) is a leading provider of cable design, assembly, and manufacturing.Founded over 40 years ago, GBE offers a highly sophisticated vertical integration that allows for a wide array of production capabilities, from compound plastic resin production, raw cable extrusion, to complex cable assembly.GBE is headquartered in Taipei, Taiwan, with two manufacturing facilities located in Dongguan and Kunshan, China, combining for over 80,000㎡ of space and more than 1500 employees.

Heron Neutron Medical Corp., established in 2017 in Hsinchu, Taiwan. AB-BNCT (Accelerator-Based Boron Neutron Capture Therapy) technology were transferred from National Tsing Hua University and Industrial Technology Research Institute. Integrate talents to provide AB-BNCT total solutions. In the past, radiation therapy mostly relied on foreign manufacturers to provide equipment and technology. HERON hopes to bring years of research results from Taiwan to global and obtain medical device certifications, allowing the domestic medical industry to advance into cutting-edge medical equipment.

HippoScreen Neurotech Corp. (HNC) was established in March 2019 by Compal Computer's direct investment in the research team of Professor Liu, Yi-Hung. The company takes EEG signal processing and artificial intelligence technology as the core, aiming to develop EEG-assisted diagnosis and medical services. Its self-developed EEG amplifier cleared FDA 510(k) at the end of 2020, completed the TFDA review, and received approval for the medical device in March 2021, becoming the first medical-grade EEG amplifier manufacturer in Taiwan.
In addition, HippoScreen also passed ISO 13485 medical device quality management system certification, received a certificate from BSI in August 2022, and registered to the BSI certification website. Through this professional international standard certification, it is expected that HippoScreen will be able to enter the worldwide market as soon as possible.

Huijia Health with patented core technology- Non-invasive Fiber Optic Physiological Monitoring Technology (nFOPT®) and Smart Care System using the principle of total reflection of optical fiber, there is no electromagnetic field change (no electromagnetic wave) in each action. It is a high-sensitivity and high-accuracy physiological sensor that can monitor changes in physiological activities such as breathing, heart rate, blood pressure, sleep analysis, and activity status. Product applications include smart (bed) films, smart beds, smart wheelchair cushions, smart assistive devices, smart care system for taking care a lot of elders and babies at the same time, etc. The technology won 2019 ECI Awards, 2017 R&D 100 Awards, 2017 Medical Quality Awards, 2016 APICTA Awards. The technology has been developed for nearly 8 years, and has been adopted by more than 250 baby and elderly care centers and over 50,000 used it. Response to COVID-19 with nFOPT® & Smart Care System using AI is that can accurately and instantaneously track various first symptoms of the virus including respiratory rate and changes, heart rate, persistent coughs, sleep quality and much more. There are more than 30 senior care centers and hospitals in Taiwan using our smart care system to prevent Covin-19.

.

IntelliGen Technology is dedicated to the research, development, and promotion of intelligent medical imaging technologies. The company specializes in transforming traditional black-and-white 2D medical images into vivid 3D color visualizations, enhancing the quality and efficiency of clinical diagnosis, surgical planning, and medical education. With independently developed AI technologies, IntelliGen Technology has established collaborations with several leading medical centers in Taiwan and is actively expanding into international markets, including ongoing discussions with partners in Germany and Luxembourg. Upholding a spirit of innovation, the company integrates cloud platforms and cross-device applications to drive the digital transformation of medical imaging, aiming to become a key force in advancing Taiwan's smart healthcare industry.